Hospital Británico de Buenos Aires is a hospital in Buenos Aires, Argentina.

During the past decade, Hospital Británico de Buenos Aires conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 30 clinical trials were completed, i.e. on average, 56.6% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 17 clinical trials were completed. i.e. 65.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Británico de Buenos Aires" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Pfizer" with 11 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Merck Sharp & Dohme LLC" with 4 trials sponsored and "Actelion" with 4 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Británico de Buenos Aires" #1 collaborator was "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Actoverco" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Applied Health Research Centre" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Británico de Buenos Aires" are "Colitis, Ulcerative" (4 trials), "Hypertension" (4 trials), "Pulmonary Hypertension" (4 trials), "Rheumatoid Arthritis" (4 trials) and "Pancreatic Cancer" (3 trials). Many other conditions were trialed in "Hospital Británico de Buenos Aires" in a lesser frequency.

Most popular intervention types in "Hospital Británico de Buenos Aires" are "Drug" (73 trials), "Biological" (11 trials), "Other" (8 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Atezolizumab" (6 trials), "Paclitaxel" (5 trials), "Carboplatin" (4 trials) and "Pembrolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Británico de Buenos Aires" are 79 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Británico de Buenos Aires". undefined are not yet recruiting, 14 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in Hospital Británico de Buenos Aires, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Británico de Buenos Aires, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 5 trials that are defined as “Not Applicable".

Hospital Británico de Buenos Aires has several departments that took part in Clinical trials: "Hospital Britanico; Oncologia" - 4 trials, "Hospital Britanico; Haematology" - 2 trials